跳至主要内容
临床试验/NL-OMON34397
NL-OMON34397已完成4 期

Steroid free immunosuppression or calcineurin inhibitor minimization after Basiliximab induction therapy in kidney transplantation: Comparison with a standard quadruple immunosuppressive regimen. - Allegro

niversitair Medisch Centrum Groningen0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria
  • Female or male, aged between 18 and 70 years.
  • Recipient of a kidney graft (first or second) from a deceased (heartbeating or non-heartbeating) donor or living (non-HLA identical) donor.
  • The patient understands the purpose and risks of the study and has given written informed consent to participate in the study.

排除标准

  • Exclusion criteria
  • Patients with multi-organ transplants
  • Patients who are receiving a third or fourth transplant.
  • Patients who have > 50 % (current or historic) panel reactive antibodies.
  • Female patients who are pregnant or unwilling to use adequate contraception during the study.

研究者

相似试验